Showing results (1-10 of 34) with videos related to
Sort By:
Pageof 4
Seminars in Vascular Medicine|October 13, 2004
Factors affecting plasma lipoprotein(a) levels: role of hormones and other nongenetic factorsKaram M Kostner, Gert M KostnerDrug News & Perspectives|April 5, 2003
The Physiological Role of Lipoprotein (a)Karam M. Kostner, Gert M. KostnerJournal of Lipid Research|November 9, 2016
Lipoprotein (a): a historical appraisalKaram M Kostner, Gert M KostnerAtherosclerosis|May 11, 2018
Is Lp(a) ready for prime time use in the clinic? A pros-and-cons debateKaram M Kostner, Gert M Kostner, Anthony S WierzbickiArteriosclerosis, Thrombosis, and Vascular Biology|January 24, 2012
FGF19 signaling cascade suppresses APOA gene expressionIndumathi Chennamsetty, Thierry Claudel, Karam M Kostner, et al.The Journal of Clinical Investigation|August 2, 2011
Farnesoid X receptor represses hepatic human APOA gene expressionIndumathi Chennamsetty, Thierry Claudel, Karam M Kostner, et al.Future Cardiology|October 7, 2009
HDL therapy: the next big step in the treatment of atherosclerosis?Karam M Kostner, Edmund CauzaInternational Journal of Molecular Sciences|April 12, 2022
Lp(a) and the Risk for Cardiovascular Disease: Focus on the Lp(a) Paradox in Diabetes MellitusKaram M Kostner, Gerhard M KostnerCurrent Opinion in Lipidology|August 2, 2002
Lipoprotein(a): still an enigma?Karam M Kostner, Gerhard M KostnerCurrent Opinion in Clinical Nutrition and Metabolic Care|November 24, 2023
The 10 essential questions regarding lipoprotein(a)Karam M Kostner, Gerhard M KostnerPageof 4